Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Making Evidence-based Decisions Using Alzheimer Therapy (MEDUSA Therapy)
ISRCTN ISRCTN55568578
ClinicalTrials.gov identifier
Public title Making Evidence-based Decisions Using Alzheimer Therapy (MEDUSA Therapy)
Scientific title
Acronym N/A
Serial number at source N0038133699
Study hypothesis What evidence is there that altering therapy, after initial treatment starts to fail, will benefit the patient?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Alzheimer's disease
Participants - inclusion criteria 75 participants, (i.e. 15 in each arm of the trial) with diagnosis of Alzheimer's disease (AD) and aged between 55 and 95.
Participants - exclusion criteria Does not match inclusion criteria
Anticipated start date 30/09/2003
Anticipated end date 01/12/2004
Status of trial Completed
Patient information material
Target number of participants 75
Interventions Randomised controlled trial (RCT):
1. Cholinesterase inhibitor (ChEi) as usual
2. Increased dose of ChEi
3. Rivastigmine
4. Memantine
5. ChEi as usual, plus memantine
Primary outcome measure(s) 1. Clinical Global Impression of Change (CGI/C)
2. Mini-Mental State Examination (MMSE)
3. BAYER-Activities of Daily Living (ADL)
4. Neuropsychiatric inventory questionnaire (NPI-Q)
5. Global Assessment Scale (GAS)
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Avon and Wiltshire Mental Health Partnership NHS Trust (UK)
Trial website
Publications
Contact name Dr  Roger  Bullock
  Address Kingshill Research Centre
Victoria Hospital
Okus Road
  City/town Swindon
  Zip/Postcode SN1 4HZ
  Country United Kingdom
  Tel +44 (0)1793 481182
  Fax +44 (0)1793 437521
  Email roger.bullock@kingshill-research.org
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 28/01/2010
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central